InvestSMART

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.047

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Less than Marketable Parcel Sale Facility 18 Jul 2025 10:50AM $0.034 $0.047 risen by 38.24%
$38 Letter to Shareholders - Notice of General Meeting 18 Jul 2025 10:42AM $0.034 $0.047 risen by 38.24%
$38 Notice of General Meeting/Proxy Form 18 Jul 2025 10:42AM $0.034 $0.047 risen by 38.24%
$38 Ceasing to be a substantial holder 30 Jun 2025 8:22AM $0.027 $0.047 risen by 74.07%
$38 Section 708A(5)(e) Notice 26 Jun 2025 11:07AM $0.025 $0.047 risen by 88%
$38 Application for quotation of securities - EMD 26 Jun 2025 11:04AM $0.025 $0.047 risen by 88%
$38 EMD Presents Medibank Deal to US Psychedelic Conference 20 Jun 2025 9:41AM $0.029 $0.047 risen by 62.07%
$38 Proposed issue of securities - EMD 18 Jun 2025 9:44AM $0.025 $0.047 risen by 88%
$38 Medibank to Fund Emyria's PTSD Program at Perth Clinic 18 Jun 2025 9:44AM $0.025 $0.047 risen by 88%
$38 Proposed issue of securities - EMD 18 Jun 2025 9:44AM $0.025 $0.047 risen by 88%
$38 Trading Halt 16 Jun 2025 9:48AM $0.025 $0.047 risen by 88%
$38 PTSD Gains Sustained at 6m Follow-Up, MOU Signed with ANU 28 May 2025 8:38AM $0.028 $0.047 risen by 67.86%
$38 Ceasing to be a substantial holder 19 May 2025 7:26PM $0.035 $0.047 risen by 34.29%
$38 Notification of cessation of securities - EMD 14 May 2025 8:17AM $0.036 $0.047 risen by 30.56%
$38 March 2025 Quarterly Activities Report and Appendix 4C 29 Apr 2025 9:33AM $0.027 $0.047 risen by 74.07%
$38 Emyria Opens New Empax Centre to Meet Demand and Payer Needs 14 Apr 2025 8:22AM $0.029 $0.047 risen by 62.07%
$38 Change of Director's Interest Notice - M. Winlo 9 Apr 2025 9:24AM $0.025 $0.047 risen by 88%
$38 Section 708A(5)(e) Notice 31 Mar 2025 5:51PM $0.031 $0.047 risen by 51.61%
$38 Becoming a substantial holder 31 Mar 2025 5:50PM $0.031 $0.047 risen by 51.61%
$38 Change of Director's Interest Notice x 2 31 Mar 2025 5:40PM $0.031 $0.047 risen by 51.61%
$38 Notification regarding unquoted securities - EMD 31 Mar 2025 5:31PM $0.031 $0.047 risen by 51.61%
$38 Application for quotation of securities - EMD 31 Mar 2025 5:16PM $0.031 $0.047 risen by 51.61%
$38 Results of Meeting 19 Mar 2025 7:25PM $0.033 $0.047 risen by 42.42%
$38 Section 708A(5)(e) Notice 5 Mar 2025 10:06AM $0.032 $0.047 risen by 46.88%
$38 Notification regarding unquoted securities - EMD 5 Mar 2025 10:03AM $0.032 $0.047 risen by 46.88%

101 - 125 of 552 results

Page 5 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.